BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 27650585)

  • 41. The human cutaneous squamous cell carcinoma microenvironment is characterized by increased lymphatic density and enhanced expression of macrophage-derived VEGF-C.
    Moussai D; Mitsui H; Pettersen JS; Pierson KC; Shah KR; Suárez-Fariñas M; Cardinale IR; Bluth MJ; Krueger JG; Carucci JA
    J Invest Dermatol; 2011 Jan; 131(1):229-36. PubMed ID: 20827282
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Roles of VEGF-Flt-1 signaling in malignant behaviors of oral squamous cell carcinoma.
    Subarnbhesaj A; Miyauchi M; Chanbora C; Mikuriya A; Nguyen PT; Furusho H; Ayuningtyas NF; Fujita M; Toratani S; Takechi M; Niida S; Takata T
    PLoS One; 2017; 12(11):e0187092. PubMed ID: 29149180
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Silencing Id-1 inhibits lymphangiogenesis through down-regulation of VEGF-C in oral squamous cell carcinoma.
    Dong Z; Wei F; Zhou C; Sumida T; Hamakawa H; Hu Y; Liu S
    Oral Oncol; 2011 Jan; 47(1):27-32. PubMed ID: 21111670
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chemokine CCL4 Induces Vascular Endothelial Growth Factor C Expression and Lymphangiogenesis by miR-195-3p in Oral Squamous Cell Carcinoma.
    Lien MY; Tsai HC; Chang AC; Tsai MH; Hua CH; Wang SW; Tang CH
    Front Immunol; 2018; 9():412. PubMed ID: 29599774
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Primary tumor induces sentinel lymph node lymphangiogenesis in oral squamous cell carcinoma.
    Ishii H; Chikamatsu K; Sakakura K; Miyata M; Furuya N; Masuyama K
    Oral Oncol; 2010 May; 46(5):373-8. PubMed ID: 20308006
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of novel prognostic markers PROX1 and FOXC2 in carcinogenesis of oral squamous cell carcinoma.
    Agnihotri NS; Astekar M
    J Exp Ther Oncol; 2018 May; 12(3):171-184. PubMed ID: 29790306
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-tumor and anti-metastatic actions of wogonin isolated from Scutellaria baicalensis roots through anti-lymphangiogenesis.
    Kimura Y; Sumiyoshi M
    Phytomedicine; 2013 Feb; 20(3-4):328-36. PubMed ID: 23219337
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transcutaneous carbon dioxide induces mitochondrial apoptosis and suppresses metastasis of oral squamous cell carcinoma in vivo.
    Takeda D; Hasegawa T; Ueha T; Imai Y; Sakakibara A; Minoda M; Kawamoto T; Minamikawa T; Shibuya Y; Akisue T; Sakai Y; Kurosaka M; Komori T
    PLoS One; 2014; 9(7):e100530. PubMed ID: 24988190
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma.
    Boonkitticharoen V; Kulapaditharom B; Leopairut J; Kraiphibul P; Larbcharoensub N; Cheewaruangroj W; Chintrakarn C; Pochanukul L
    Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1305-11. PubMed ID: 19075127
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities.
    Xu Y; Lu W; Yang P; Peng W; Wang C; Li M; Li Y; Li G; Meng N; Lin H; Kan L; Wang S; Yang S; Yu L; Zhao Y
    BMC Cancer; 2015 Jul; 15():525. PubMed ID: 26187637
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyclooxygenase-2 promotes tumor lymphangiogenesis and lymph node metastasis in oral squamous cell carcinoma.
    Morita Y; Hata K; Nakanishi M; Nishisho T; Yura Y; Yoneda T
    Int J Oncol; 2012 Sep; 41(3):885-92. PubMed ID: 22735610
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Head and neck squamous cell carcinoma lymphatic spread and survival: Relevance of vascular endothelial growth factor family for tumor evaluation.
    de Sousa EA; Lourenço SV; de Moraes FP; Vartanian JG; Gonçalves-Filho J; Kowalski LP; Soares FA; Coutinho-Camillo CM
    Head Neck; 2015 Oct; 37(10):1410-6. PubMed ID: 24824527
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SAR131675, a potent and selective VEGFR-3-TK inhibitor with antilymphangiogenic, antitumoral, and antimetastatic activities.
    Alam A; Blanc I; Gueguen-Dorbes G; Duclos O; Bonnin J; Barron P; Laplace MC; Morin G; Gaujarengues F; Dol F; Hérault JP; Schaeffer P; Savi P; Bono F
    Mol Cancer Ther; 2012 Aug; 11(8):1637-49. PubMed ID: 22584122
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multi-kinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinase.
    Matsui J; Funahashi Y; Uenaka T; Watanabe T; Tsuruoka A; Asada M
    Clin Cancer Res; 2008 Sep; 14(17):5459-65. PubMed ID: 18765537
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Curcumin inhibits lymphangiogenesis in vitro and in vivo.
    Wang W; Sukamtoh E; Xiao H; Zhang G
    Mol Nutr Food Res; 2015 Dec; 59(12):2345-54. PubMed ID: 26375757
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma].
    Lu ZQ; Li HG; Xie DR; Zhang HZ; Shen XM; Zeng YJ; Zeng H
    Ai Zheng; 2005 Sep; 24(9):1132-5. PubMed ID: 16159440
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumour cell-derived WNT5B modulates in vitro lymphangiogenesis via induction of partial endothelial-mesenchymal transition of lymphatic endothelial cells.
    Wang SH; Chang JS; Hsiao JR; Yen YC; Jiang SS; Liu SH; Chen YL; Shen YY; Chang JY; Chen YW
    Oncogene; 2017 Mar; 36(11):1503-1515. PubMed ID: 27593938
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of recombinant VEGF-C secreted from eukaryotic cells on proliferation and chemotherapy-induced apoptosis of leukemic cells].
    Ding KY; Bai X; Dai L; Dong NZ; Ruan CG
    Ai Zheng; 2005 Sep; 24(9):1037-42. PubMed ID: 16159421
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased Wnt5a in squamous cell lung carcinoma inhibits endothelial cell motility.
    Rapp J; Kiss E; Meggyes M; Szabo-Meleg E; Feller D; Smuk G; Laszlo T; Sarosi V; Molnar TF; Kvell K; Pongracz JE
    BMC Cancer; 2016 Nov; 16(1):915. PubMed ID: 27876017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.